Bottom line
THISX vs JDOC: the short answer
THISX (T. Rowe Price Health Sciences Fund, Inc.) and JDOC (JPMorgan Healthcare Leaders ETF) are both mutual funds.
But THISX is far broader, holding 279 positions to 61 for JDOC, so beyond the top names it adds exposure JDOC doesn't have.
JDOC is cheaper at 0.65% vs 0.68% — a difference of $3.00 a year per $10,000 invested.
Over one year, THISX returned +17.9% vs +14.9% for JDOC.
Updated Nov 19, 2026
THISX vs JDOC side by side
| THISX | JDOC | |
|---|---|---|
| Type | Mutual fund | ETF |
| Fund family | T. Rowe Price | J.P. Morgan |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.68% | 0.65% |
| Annual cost per $10k | $68 | $65 |
| 10-yr cost on $10k (prospectus) | $847 | $810 |
| Max front load | — | None |
| 12b-1 fee | — | — |
| 1-yr return | +17.9% | +14.9% |
| 5-yr return (annualized) | +4.3% | — |
| 10-yr return (annualized) | — | — |
| Best quarter | +23.5% | +11.3% |
| Worst quarter | −15.8% | −11.9% |
| Net assets (fund) | $11.9B | $9.1M |
| Number of holdings | 279 | 61 |
| Portfolio turnover | 62% | 92% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Holdings overlap
13 of THISX's top 25 holdings also appear in JDOC's top 25.
| Holding | THISX | JDOC |
|---|---|---|
| Eli Lilly & Co | 14.28% | 7.76% |
| Johnson & Johnson | 6.63% | 4.82% |
| Unitedhealth Group Inc | 5.99% | 5.85% |
| Abbvie Inc | 5.10% | 7.85% |
| Merck & Co. Inc. | 4.01% | 4.82% |
| Thermo Fisher Scientific Inc | 2.52% | 3.73% |
| Bristol-myers Squibb Co | 2.11% | 3.57% |
| Abbott Laboratories | 1.89% | 3.11% |
| Intuitive Surgical Inc | 1.87% | 1.93% |
| Stryker Corp | 1.78% | 2.23% |
| Danaher Corp | 1.43% | 2.16% |
| Cardinal Health Inc | 1.03% | 1.51% |
| Cvs Health Corp | 0.94% | 2.83% |
Source: SEC Form N-PORT
THISX top 10
- Eli Lilly & Co — 14.28%
- Johnson & Johnson — 6.63%
- Unitedhealth Group Inc — 5.99%
- Abbvie Inc — 5.10%
- Merck & Co. Inc. — 4.01%
- Gilead Sciences Inc — 2.82%
- Thermo Fisher Scientific Inc — 2.52%
- Vertex Pharmaceuticals Inc — 2.28%
- Bristol-myers Squibb Co — 2.11%
- Abbott Laboratories — 1.89%
JDOC top 10
- AbbVie, Inc. — 7.85%
- Eli Lilly & Co. — 7.76%
- UnitedHealth Group, Inc. — 5.85%
- Merck & Co., Inc. — 4.82%
- Johnson & Johnson — 4.82%
- AstraZeneca plc — 3.76%
- Thermo Fisher Scientific, Inc. — 3.73%
- Bristol-Myers Squibb Co. — 3.57%
- Abbott Laboratories — 3.11%
- CVS Health Corp. — 2.83%
FAQ
What is the difference between THISX and JDOC?
Which is cheaper, THISX or JDOC?
Should I own both THISX and JDOC?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.